Akso Health Group DRC (AHG)

Akso Health Group DRC (AHG) is a NASDAQ-listed depositary receipt representing common stock of Akso Health Group. The underlying business, through its subsidiaries, operates a social e-commerce mobile platform in China centered on the Xiaobai Maimai app. Its platform distributes a range of consumer products, including food and beverages, wine, cosmetics, fashion and apparel, entertainment items, housewares, and home appliances, and also features cost-saving promotions at petrol gas stations. Beyond its e-commerce activities, the company sells medical devices such as defibrillators and anesthesia laryngoscopes, and provides health treatment, consultancy support, marketing promotion, technological promotion, and import and export services. Formerly known as Xiaobai Maimai Inc., the company adopted the Akso Health Group name in December 2021 and was founded in 2014. It is headquartered in Qingdao, China.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-AHG
$0.42
-42.8% Downside
Overvalued
Not available
Not available
Fair
0.0%
3.6x
47.1x
634 M
653.3 M
0.4%
99.7%
27.4
68.5%
Valuation • Fair Value

Akso Health Group DRC (NASDAQ-AHG) Fair Value by Valuation Model

Review the available estimates for Akso Health Group DRC (NASDAQ-AHG), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.42

Estimated downside of 42.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.35

Discounted cash flow valuation reference.

Comps Fair Value

$0.46

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Akso Health Group DRC (NASDAQ-AHG) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Akso Health Group DRC (NASDAQ-AHG)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

13.832 M

Current operating scale indicator.

Revenue Forecast

13.832 M

Forward revenue estimate.

EBITDA

-1.628 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Akso Health Group DRC (NASDAQ-AHG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Akso Health Group DRC (NASDAQ-AHG)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

9.12

Higher caution zone on this screen.

Altman Z-Score

27.4

Relatively strong balance-sheet zone.

FCF / Net Income

68.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Akso Health Group DRC (NASDAQ-AHG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Akso Health Group DRC (NASDAQ-AHG)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Akso Health Group DRC (NASDAQ-AHG). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Akso Health Group DRC (NASDAQ-AHG) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Akso Health Group DRC (NASDAQ-AHG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Akso Health Group DRC (NASDAQ-AHG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Akso Health Group DRC (NASDAQ-AHG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Akso Health Group DRC (NASDAQ-AHG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Akso Health Group DRC (NASDAQ-AHG) Stock FAQ

Data-supported answers about Akso Health Group DRC (NASDAQ-AHG), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.42
Estimated downside 42.8%
Valuation Rating
Overvalued
Estimated downside of 42.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Akso Health Group DRC (NASDAQ-AHG) is $0.42. This implies an estimated downside of 42.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 42.8% versus the current market price.

The current financial health read for Akso Health Group DRC (NASDAQ-AHG) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Akso Health Group DRC (NASDAQ-AHG).

The current market capitalization listed for Akso Health Group DRC is 634 M.

The current enterprise value listed for Akso Health Group DRC is 653.3 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Akso Health Group DRC is NASDAQ-AHG, and the stock is listed on NASDAQ.

Akso Health Group DRC (NASDAQ-AHG) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Akso Health Group DRC is 0.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Akso Health Group DRC is 99.7%. Free float helps investors understand how much of the share base is available for public trading.